Log In
BCIQ
Print this Print this
 

VK5211 (formerly LGD-4033)

  Manage Alerts
Collapse Summary General Information
Company Ligand Pharmaceuticals Inc.
DescriptionNon-steroidal selective androgen receptor modulator (SARM)
Molecular Target Androgen receptor
Mechanism of ActionSelective androgen receptor modulator (SARM)
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1,531.5M

0

$1,500.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/22/2014

$1,531.5M

0

$1,500.0M

Get a free BioCentury trial today